Back to DnB Asset Management AS DnB Asset Management AS

MRNA

Showing 6 of 23 quarters

Position history for DnB Asset Management ASDnB Asset Management AS's holdings in Moderna, Inc.

Yes. DnB Asset Management holds 48,448 shares of MRNA (Moderna), worth $3.4M, as of its Q2 2026 13F filing. It reduced the position by 3,453 shares (-6.7%) from Q1 2026. DnB Asset Management has held MRNA since Q1 2026, across 2 quarterly 13F filings.

Current Value

$3.4M

Current Shares

48,448

Total Value Change

-$275,486

Total Shares Change

-6,442

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
48,448
-6.7%
$3.4M0.0%$70.03
0
2026-Q1
New
51,901
-
$2.6M0.0%$50.80
36
2025-Q2
Exited
0
-100.0%
$00.0%$27.59
0
2025-Q1
Increased
60,875
+5.4%
$1.7M0.0%$28.35
27
2024-Q4
Increased
57,755
+5.2%
$2.4M0.0%$41.58
28
2024-Q3
Increased
54,890
+3.6%
$3.7M0.0%$65.75
28

Other major holders of MRNA: Baillie Gifford & Co.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used